Secondary aim: Assessment of the protective effect of L-carnitine on bowel function and habits in patients with DRE on KD by assessing frequency of defecation, stool form and response to laxatives
THE CUSTOMER ACKNOWLEDGES THAT THERE ARE RISKS IN THE HANDLING, USE, AND DISTRIBUTION OF THESE PRODUCTS, AND CERTIFIES THAT IT HAS THE PROPER EQUIPMENT, FACILITIES, AND PERSONNEL FOR MANAGING THOSE RISKS
Notes Text in parentheses is additional optional information which can be included on the label at the applicant's discretion
If you notice particles, cloudiness, or discoloration, do not use that vial and contact the pharmacy for guidance
Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A: Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency